Not intended for animal, human, diagnostic, or therapeutic use “Research
& Development Purposes Only”
|
|
|
Suitability
|
antiviral; potent and selective inhibitors of
varicella zoster virus, is a potential fast-acting, therapy for herpes zoster
(shingles) and for the reduction of shingles-associated pain and
post-herpetic neuralgia (PHN), the small-molecule compound has been shown to inhibit
the replication of varicella zoster virus (VZV) substantially faster than
other antivirals more potently currently approved for the treatment of
shingles. (MANUAL REVIEW)
|
|
|
COA
|
Available upon request:
|
MSDS
|
Available upon request:
|
|
|
Product
|
Product number Purity Grade CAS number Lot number Appearance Assay Elemental
analysis Identification Solubility Retest date
|
FIC956483037-250MG 98.9%,
for immunohistochemistry Certified® 956483-03-7 122220.1105AM
light
brown powder (HPLC)
98.9% (carbon)
60.72% (hydrogen)
6.79% (nitrogen)
7.87% confirms in
DMSO 12/2022
|
|
|
|
Properties
|
Cas number
|
956483-03-7
|
Boiling point
|
°C
|
Density
|
|
EINECS or EC
|
|
Flash point
|
°C
|
Formula
|
C27H35N3O6.HCl
|
Melting point
|
°C
|
Molecular weight
|
534.05
|
Refractive index
|
|
Solubility in water
|
insoluble
|
|
|
|
NFPA & STORAGE
|
DOMESTIC
& INTERNATIONAL SHIPPING
|
Health
|
1
|
Flammability
|
0
|
Instability
|
0
|
Special hazard
|
|
CA Prop 65
|
No
|
Storage
|
General
|
Color code
|
Green
|
|
(Domestic Inside 48 Contiguous USA, Ground)
|
Not dangerous goods
|
|
|
(International Outside 48 Contiguous USA, Air)
|
Not dangerous goods
|
|
|
|